Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Egypt / NCT03770936
Recruiting Phase 3

Effect of Some Drugs on Liver Fibrosis

NCT03770936 · tracked via the Priya Life Science Egypt tracker
Sponsor
Sherief Abd-Elsalam
Phase
Phase 3
Started
2018-10-01
Last updated
2018-12-10

Condition(s) studied

Liver Fibroses

Investigational drug(s) / intervention(s)

Candesartan →Ramipril →

Candesartan: Candesartan 8 mg/day

Ramipril: ramipril 1.25 mg/day

Study summary

Effect of Some Drugs on Liver Fibrosis

Eligibility

Sex
ALL
Min age
20 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * chronic hepatitis C Exclusion Criteria: * Acute hepatitis * Thalassemia

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Sherief Abd-Elsalam Tanta Egypt Recruiting

On this site

📄 Atacand (candesartan) drug profile → 📄 Altace (ramipril) drug profile →

More Sherief Abd-Elsalam trials in Egypt

Citicoline as Neuroprotector in Neonates Exposed to Hypoxia Recruiting
Pantoprazole in Cisplatin Nephrotoxicity Recruiting
Clinical Study Evaluating Beta Blockers Use and Fracture Risk in Patients With Primary Osteoporosis Recruiting
Docosahexaenoic Acid on Breath Holding Spells in Children Recruiting
Effect of Some Drugs on Rheumatoid Arithritis Activity Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03770936 on ClinicalTrials.gov ↗ ← All trials in Egypt